Clinical Trials Directory

Trials / Completed

CompletedNCT02510729

SPG Neurostimulation in Cluster Patients

Sphenopalataine Ganglion (SPG) Stimulation in Cluster Headache Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Danish Headache Center · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

We hypothesized that LF stimulation of the SPG would increase parasympathetic outflow, activate sensory afferents and provoke a cluster-like attack.

Detailed description

We conducted a double-blind, randomized, sham-controlled, crossover study to investigate cluster attack induction following LF (20 Hz and 0.2-2.1 amplitude) and sham (amplitude = 0) stimulation in 20 CH patients with implanted SPG neurostimulator. In addition, we measured plasma concentrations of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal peptide (VIP), as markers for parasympathetic activation before, during and after SPG stimulation. We also investigated if LF SPG stimulation induces changes in cardiac autonomic regulation and whether any attacks induced by SPG stimulation are associated with such changes.

Conditions

Interventions

TypeNameDescription
DEVICENeurostimulation
DEVICESham stimulation

Timeline

Start date
2015-07-01
Primary completion
2016-05-01
Completion
2016-10-01
First posted
2015-07-29
Last updated
2017-08-16

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT02510729. Inclusion in this directory is not an endorsement.